Stock Events

Medpace 

$386.65
110
+$4.18+1.09% Friday 20:00

Statistics

Day High
389.79
Day Low
380
52W High
459.77
52W Low
227.21
Volume
194,208
Avg. Volume
373,979
Mkt Cap
11.99B
P/E Ratio
36.34
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21OctConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
1.8
2.27
2.73
3.2
Expected EPS
2.799967
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MEDP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

426.5$Average Price Target
The highest estimate is $480.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
78%
Hold
22%
Sell
0%

About

Commercial Services
Miscellaneous Commercial Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
August Troendle
Employees
5800
Country
US
ISIN
US58506Q1094
WKN
000A2APTV

Listings